These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14603122)

  • 1. Clinical proteomics: new promises for early cancer detection.
    Mariani SM
    MedGenMed; 2003 Apr; 5(2):23. PubMed ID: 14603122
    [No Abstract]   [Full Text] [Related]  

  • 2. ACS releases updated guidelines on cancer screening.
    Lambert M
    Am Fam Physician; 2012 Sep; 86(6):571, 576-7. PubMed ID: 23062051
    [No Abstract]   [Full Text] [Related]  

  • 3. Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Andriole GL
    Recent Results Cancer Res; 2014; 202():53-7. PubMed ID: 24531777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.
    Grubb RL; Pinsky P; Prorok PC; Andriole GL
    Eur Urol; 2015 Oct; 68(4):545-6. PubMed ID: 25959167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection.
    Smith RA; von Eschenbach AC; Wender R; Levin B; Byers T; Rothenberger D; Brooks D; Creasman W; Cohen C; Runowicz C; Saslow D; Cokkinides V; Eyre H;
    CA Cancer J Clin; 2001; 51(1):38-75; quiz 77-80. PubMed ID: 11577479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A different interpretation of the efficacy of lung cancer screening in the PLCO trial.
    Sagawa M; Nakayama T; Sobue T;
    Eur J Epidemiol; 2016 Feb; 31(2):211-2. PubMed ID: 26197850
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
    Smith RA; Brooks D; Cokkinides V; Saslow D; Brawley OW
    CA Cancer J Clin; 2013; 63(2):88-105. PubMed ID: 23378235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis.
    Wright GL
    Expert Rev Mol Diagn; 2002 Nov; 2(6):549-63. PubMed ID: 12465452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.
    Smith RA; Andrews KS; Brooks D; Fedewa SA; Manassaram-Baptiste D; Saslow D; Brawley OW; Wender RC
    CA Cancer J Clin; 2017 Mar; 67(2):100-121. PubMed ID: 28170086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 12. ERSPC, PLCO studies and critique of cochrane review 2013.
    Schröder FH
    Recent Results Cancer Res; 2014; 202():59-63. PubMed ID: 24531778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Hasson MA; Fagerstrom RM; Kahane DC; Walsh JH; Myers MH; Caughman C; Wenzel B; Haralson JC; Flickinger LM; Turner LM;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):329S-348S. PubMed ID: 11189686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel form of prostate-specific antigen transcript produced by alternative splicing.
    Tanaka T; Isono T; Yoshiki T; Yuasa T; Okada Y
    Cancer Res; 2000 Jan; 60(1):56-9. PubMed ID: 10646852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer cell secretome: a good source for discovering biomarkers?
    Pavlou MP; Diamandis EP
    J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alu Retroelement Copy Number and Lung Cancer Risk in the Prospective Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Wong JYY; Cawthon R; Hu W; Ezennia S; Gadalla SM; Breeze C; Blechter B; Freedman ND; Huang WY; Hosgood HD; Seow WJ; Bassig BA; Rahman ML; Hayes RB; Rothman N; Lan Q
    Chest; 2022 Oct; 162(4):942-945. PubMed ID: 35609672
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.
    Smith RA; Cokkinides V; Brawley OW
    CA Cancer J Clin; 2009; 59(1):27-41. PubMed ID: 19147867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical proteomics--insights into pathologies and benefits for patients.
    Banks R; Selby P
    Lancet; 2003 Aug; 362(9382):415-6. PubMed ID: 12927423
    [No Abstract]   [Full Text] [Related]  

  • 20. Focused Decision Support: a Data Mining Tool to Query the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset and Guide Screening Management for the Individual Patient.
    Sharma A; Hostetter J; Morrison J; Wang K; Siegel E
    J Digit Imaging; 2016 Apr; 29(2):160-4. PubMed ID: 26385814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.